The European Union adopted new legislation on plants obtained through certain new genomic techniques in June 2026. The new framework will apply after a two-year transition period. It distinguishes ...

FDA clearance of the IND, together with the previously cleared CTA, establishes a global Phase 1/2 clinical program for PM577a -- ...

The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most ...

In a recent study published in Science, researchers might have found a potential explanation for why men tend to die earlier ...

Screwworms are back and spreading in Texas. The pests were successfully eradicated from the United States in 1966. How? Using the sterile insect technique whereby 20 billion irradiated screwworm flies ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced participation in a consortium selected to receive funding from ...

Enhancers are pieces of DNA that act like switches, regulating when genes are turned on and off and how strongly they are ...

Beam to Host Investor Webcast to Review BEAM-302 Clinical Data on Tuesday, September 8, 2026, at 7:00 a.m. ET CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE)-- Beam Therapeutics Inc. (Nasdaq: BEAM), ...

Enhancers are pieces of DNA that act like switches, regulating when genes are turned on and off and how strongly they are activated.

Testing thousands of genes in living tumors revealed hidden drivers of aggressive basal-like breast cancer that cell cultures ...

Researchers used AI to create variants of a CRISPR-Cas12-like nuclease, some of which show increased editing activity ...

By identifying the genes and molecules crucial to resistance in American chestnuts and other species, researchers hope to use ...